| Ident. | Authors (with country if any) | Title |
|---|
| 000130 (2013) |
Indranil Dey [Canada] ; Nisha Midha [Canada] ; Geeta Singh [Canada] ; Amanda Forsyth [Canada] ; Sarah K. Walsh [Canada] ; Bhagat Singh [Canada] ; Ranjan Kumar [Canada] ; Cory Toth [Canada] ; Rajiv Midha [Canada] | Diabetic Schwann cells suffer from nerve growth factor and neurotrophin‐3 underproduction and poor associability with axons |
| 000603 (2010) |
Jun Liu [République populaire de Chine, États-Unis] ; Min Shi [États-Unis] ; Zhen Hong [République populaire de Chine] ; Jianpeng Zhang [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; Shengdi Chen [République populaire de Chine] ; Jing Zhang [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein |
| 000734 (2009) |
Josep M. Aparicio [Canada] ; Godelieve Deblonde [Canada] ; Louis Garand [Canada] ; Stéphane Laroche [Canada] | Signature of the atmospheric compressibility factor in COSMIC, CHAMP, and GRACE radio occultation data |
| 000759 (2009) |
P J Mease [États-Unis] ; K. Hobbs [États-Unis] ; A. Chalmers [Canada] ; H. El-Gabalawy [Canada] ; A. Bookman [Canada] ; E. Keystone [Canada] ; D E Furst [États-Unis] ; P. Anklesaria [États-Unis] ; A E Heald [États-Unis] | Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study |
| 000777 (2009) |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
| 000973 (2007) |
P. T. T. Ly [Canada] ; S. Singh [Canada] ; C. A. Shaw [Canada] | Novel environmental toxins: Steryl glycosides as a potential etiological factor for age‐related neurodegenerative diseases |
| 000A55 (2007) |
Gonzalo Arboleda [Royaume-Uni, Colombie] ; Tze-Jen Huang [Royaume-Uni] ; Catherine Waters [Royaume-Uni] ; Alex Verkhratsky [Royaume-Uni] ; Paul Fernyhough [Royaume-Uni, Canada] ; Rosemary M. Gibson [Royaume-Uni] | Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells |
| 000B46 (2006) |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
| 001025 (2001) |
Patrick Robert [France] ; Alan C. Peterson [Canada] ; Joël Eyer [France] | Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA |
| 001057 (2001) |
Carol J. E. Schwartz [Canada] ; Heidi M. Sampson [Canada] ; Daniela Hlousek [Canada] ; Anthony Percival-Smith [Canada] ; John W. R. Copeland [Canada] ; Andrew J. Simmonds [Canada] ; Henry M. Krause [Canada] | FTZ‐Factor1 and Fushi tarazu interact via conserved nuclear receptor and coactivator motifs |
| 001104 (2000) |
K. Watabe [Japon] ; T. Ohashi [Japon] ; T. Sakamoto [Japon] ; Y. Kawazoe [Japon] ; T. Takeshima [Japon] ; K. Oyanagi [Japon] ; K. Inoue [Japon] ; Y. Eto [Japon] ; S. U. Kim [Canada] | Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line‐derived neurotrophic factor |
| 001156 (2000) |
Gérald J. Prud'Homme [Canada] ; Ciriaco A. Piccirillo [Canada] | The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases |
| 001397 (1999) |
Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Esther Cubo [États-Unis] | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state |
| 001534 (1998) |
Douglas G. Walker [Canada, États-Unis] ; Kazuhiro Terai [Canada, Japon] ; Akinori Matsuo [Canada, Japon] ; Thomas G. Beach [Canada, États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases |
| 001678 (1997) |
Xin Lu [Canada] ; Theo Hagg [Canada] | Glial cell line‐derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats |
| 001681 (1997) |
Gary A. Johnson ; Robert Mannel ; Mahmoud Khalifa [Canada] ; Joan L. Walker ; Mary Wren [États-Unis] ; Kyung-Whan Min ; Doris M. Benbrook | Epidermal Growth Factor Receptor in Vulvar Malignancies and Its Relationship to Metastasis and Patient Survival |
| 001836 (1996) |
Yulin Liu [Canada, États-Unis] ; Karina F. Meiri [États-Unis] ; Max S. Cynader [Canada] ; Qiang Gu [Canada] | Nerve growth factor induced modification of presynaptic elements in adult visual cortex in vivo |
| 001855 (1996) |
Giuseppe Moretto ; Douglas G. Walker [États-Unis] ; Paola Lanteri ; Federica Taioli ; Stefano Zaffagnini ; Ren Y. Xu [États-Unis] ; Nicolo Rizzuto | Expression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro |
| 001A28 (1995) |
Weiya Ma [Canada] ; A. Ribeiro-Da-Silva [Canada] ; G. Noel [Canada] ; J. Julien [Canada] ; A. Claudio Cuello [Canada] | Ectopic Substance P and Calcitonin Gene‐related Peptide Immunoreactive Fibres in the Spinal Cord of Transgenic Mice Over‐expressing Nerve Growth Factor |
| 001B40 (1994) |
I. Tooyama [Canada, Japon] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada, Japon] ; H. Kimura [Japon] ; P. L. Mcgeer [Canada] | Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease |
| 001C91 (1993) |
P. Liberini [Canada] ; E. P. Pioro [Canada] ; D. Maysinger [Canada] ; F. R. Ervin [Canada] ; A. C. Cuello [Canada] | Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction |
